Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

232

HTML

1014

Figures (1-1)

128

Tables (1-4)

116

Sum=1490

Jan 28, 2007 (publication date) through Apr 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 28, 2007; 13(4): 579-584
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.579

Table 3 Frequency of laboratory abnormalities (n = 58)

Citation: Witthoeft T, Fuchs M, Ludwig D. Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study. World J Gastroenterol 2007; 13(4): 579-584
URL: https://www.wjgnet.com/1007-9327/full/v13/i4/579.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i4.579